1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. USA TRANSPLANT MARKET, BY TYPE
5.1. Introduction
5.2. Tissue Transplant
5.3. Organ Transplant
5.3.1. Living Donors
5.3.2. Deceased Donors
6. USA TRANSPLANT MARKET, BY PROCEDURE
6.1. Introduction
6.2. Autotransplantation
6.3. Allotransplantation
6.4. Xenotransplantation
7. USA TRANSPLANT MARKET, BY PRODUCT
7.1. Introduction
7.2. Immunosuppressive drugs
7.3. Preservation Solutions
7.4. Organ Transport Systems
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. TransMedics, Inc.
9.2. Veloxis Pharmaceuticals, Inc.
9.3. Bridge to Life Ltd.
9.4. Paragonix Technologies Inc.
9.5. Global Transplant Solutions
9.6. AbbVie, Inc.
9.7. Arthrex, Inc.
9.8. Medtronic
9.9. Novartis AG
9.10. Stryker